Skip to content
Top Globe News – Lifestyle
Author:
Ratio Therapeutics Inc.
/C O R R E C T I O N — Ratio Therapeutics Inc./
June 30, 2026
Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
June 30, 2026
Ratio Therapeutics and PharmaLogic Expand Manufacturing Collaboration to Support Clinical Development of [Ac-225]RTX-2358
May 29, 2026